AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

AMN · NYSE · Medical - Care Facilities

AMN

Supplies healthcare staffing, managed services, language access, and workforce technology to U.S. providers.

$34.62

After-hours close+0.01 (+0.03%)

At close$34.61(−1.34%)

Something off on this page? Send us feedback.

Profile

AMN Healthcare Services, Inc.AMNHealth Care

Combines nurse and allied staffing, physician and leadership solutions, and workforce technology for U.S. healthcare organizations. Revenue remains tied most heavily to nurse and allied demand, while language services, vendor management, and managed-service programs broaden the platform.

Runs a healthcare workforce platform centered on Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. Services include travel nurse and allied staffing, locum tenens, interim leadership, executive search, managed-service programs, vendor management systems, language services, workforce optimization, and talent planning.

Works mainly for U.S. healthcare organizations, from hospitals and health systems to other care settings. The model combines clinician and interpreter networks with staffing operations, managed-services processes, and software that helps clients source, schedule, and manage labor.

Depends on healthcare staffing cycles, especially travel nurse demand and bill rates, with one large health-system customer contributing a material share of revenue. Labor-disruption projects can lift volumes unevenly, while vendor-management activity moves with broader staffing utilization.

Company facts

CEOCaroline S. Grace

ListedNov 13, 2001

ExchangeNYSE

HeadquartersDallas, TX

CountryUnited States

Employees2,664

CIK0001142750

ISINUS0017441017

Key statistics

Market cap$1.34B

EPS (ttm)$2.68

P/E (ttm)12.92

ROE15.3%

P/B1.82

P/S0.3910

Dividend yield—

Beta0.89vs XLV 0.50

Year to date +129% · Average volume (30d) 681.9K

Analysts

Price target, next 12 months$34.00−1.8%Median of 17 analysts · vs the Aug 28 close

ConsensusBuy10 of 17 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $34.62

High$40.00+15.5%

Median$34.00−1.8%

Low$26.00−24.9%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
Aug 7, 2026	Robert W. Baird	Target		$26	$36
Jul 22, 2026	Truist Financial	Target		$26	$40
May 13, 2026	UBS	Reiterate	Neutral	$19.50	$32
May 11, 2026	BMO Capital	Reiterate	Outperform	$22	$26
May 11, 2026	Robert W. Baird	Target		$23	$26

Earnings

EPS

Estimate$0.22

ReportedDue Nov 5, 2026

Revenue

Estimate$648.9M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 6, 2026Q2 FY26	$0.19	$0.77	+307.8%	$628.4M	$673.2M	+7.1%	+16.88%
May 7, 2026Q1 FY26	$1.60	$2.10	+31.3%	$1.23B	$1.38B	+11.7%	+29.04%
Feb 19, 2026Q4 FY25	$0.22	$0.22	0.0%	$723.7M	$748.2M	+3.4%	+11.81%
Nov 6, 2025Q3 FY25	$0.19	$0.39	+105.3%	$723.1M	$634.5M	−12.3%	−3.04%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$689.5M	$658.2M	$634.5M	$748.2M	$1.38B	$673.2M
Gross profit	$198.1M	$196.4M	$184.4M	$195.1M	$368.8M	$205.9M
Operating income	$12.5M	−$123.7M	$8.4M	$8.2M	$117.2M	$26.9M
Net income	−$1.1M	−$116.2M	$29.3M	−$7.7M	$62.2M	$21.2M
Diluted EPS	−$0.03	−$3.02	$0.76	−$0.20	$1.59	$0.53
Gross margin	28.7%	29.8%	29.1%	26.1%	26.8%	30.6%
Operating margin	1.8%	-18.8%	1.3%	1.1%	8.5%	4.0%

Fiscal years (4-quarter sums)FY21 $3.98B · FY22 $5.24B · FY23 $3.79B · FY24 $2.98B · FY25 $2.73B

Revenue by product · Q2 FY26

Technology Enabled Services$84.8M · 85%

Permanent Placement$15.1M · 15%

Balance sheet, Jun 30, 2026Cash & short-term investments $361.8M · Total debt $775.8M · Total assets $2.36B · Shareholders' equity $741.3M

Dividends

No dividends on record.

Ownership

Institutions 124.67%Insiders 0.77%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 38.79M · Float 38.39M · 99.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	6.64M	17.13%	13F	Aug 7, 2026
Morgan Stanley	2.08M	5.40%	13G	Aug 13, 2026
Vanguard Capital Management LLC	1.72M	4.43%	13F	Aug 13, 2026
State Street Corp	1.69M	4.37%	13F	Aug 7, 2026
Boston Partners	1.67M	4.32%	13F	Aug 4, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Jun 15, 2026	Mark G. Foletta	director	−3,681	$31.07